Premium
Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10‐year follow‐up by automated and quantitative immunocytochemical assays
Author(s) -
Charpin Colette,
Garcia Stéphane,
Bonnier Pascal,
Martini François,
Andrac Lucile,
Horschowski Nicole,
Lavaut MarieNoëlle,
Allasia Claude
Publication year - 1998
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/(sici)1096-9896(199804)184:4<401::aid-path1220>3.0.co;2-u
Subject(s) - immunoperoxidase , immunohistochemistry , proportional hazards model , breast carcinoma , breast cancer , survival analysis , medicine , metastasis , pathology , immunocytochemistry , oncology , carcinoma , metastasis suppressor gene , log rank test , cancer , monoclonal antibody , antibody , immunology
Abstract The Nm23 gene has been described as an antimetastatic gene; in some studies, disease progression in patients with solid tumours is related to Nm23 protein expression, which can be detected by immunohistochemical procedures. Detection of Nm23‐H 1 protein in breast cancer may be relevant for the monitoring of patient therapy, provided that the technical procedures are reliable and cost‐effective. The aim of the present study was to determine the prognostic significance of Nm23, assessed by quantitative immunocytochemical assays (Nm23 ICAs), under optimal technical conditions. Nm23‐H 1 ICAs were performed on frozen sections, using an automated immunoperoxidase technique (Ventana) and computer‐assisted analysis of digitized colour microscopic images (SAMBA), in a series of 168 breast carcinomas. The results of automated quantitative ICAs were correlated with patients' follow‐up (129 months). Nm23‐H 1 immunocytochemical expression in histological sections of tumours in which more than 3 per cent of the surface area was positively stained was significantly (0·012) correlated with longer metastasis‐free survival in both node‐positive and node‐negative groups of patients ( P =0·032 and P =0·036, respectively) (Kaplan–Meier log‐rank test, NCSS 6.0.1 software). Nm23 expression (cut‐point 3 per cent) did not, however, correlate with overall survival, or with the recurrence‐free survival. In multivariate analysis (proportional hazards regression, Cox model), the prognostic significance of Nm23 in terms of metastasis‐free survival was independent of tumour size and grade, and of histological grade, in the entire cohort of patients. It is concluded that Nm23 immunodetection is only of limited practical clinical relevance in breast carcinoma, even when assessed under optimal technical conditions. © 1998 John Wiley & Sons, Ltd.